Prevention of Acute Exacerbations of COPD

2014/10/16 by Gerard J. Criner, Jean Bourbeau, Rebecca L. Diekemper +24 · 26 citations
Medicine · #Chronic Obstructive Pulmonary Disease (COPD) Research #Respiratory and Cough-Related Research #Clinical practice guidelines implementation

paper · pdf · doi:10.1378/chest.14-1676

Citations

• The natural history of chronic airflow obstruction.
• Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress

Cited by

• Role of Vaccination in the Prevention of ECOPD
• N-acetylcysteine in COPD: why, how, and when? [europepmc]
• Inhaled corticosteroids and the increased risk of pneumonia: what's new? A 2015 updated review. [europepmc]
• Rural and remote care: Overcoming the challenges of distance. [europepmc]
• Acute exacerbation of COPD. [europepmc]
• Hospital readmissions for COPD: a retrospective longitudinal study. [europepmc]
• Roles of roflumilast, a selective phosphodiesterase 4 inhibitor, in airway diseases. [europepmc]
• Chronic Obstructive Pulmonary Disease Phenotypes: Implications for Care. [europepmc]
• Home-based Physical Activity Coaching, Physical Activity, and Health Care Utilization in Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Disease Self-Management Activation Research Trial Secondary Outcomes. [europepmc]
• Development of a patient-centred, evidence-based and consensus-based discharge care bundle for patients with acute exacerbation of chronic obstructive pulmonary disease. [europepmc]
• Participation in Pulmonary Rehabilitation after Hospitalization for Chronic Obstructive Pulmonary Disease among Medicare Beneficiaries. [europepmc]
• Antioxidants and Chronic Obstructive Pulmonary Disease. [europepmc]
• The impact of integrated disease management in high-risk COPD patients in primary care. [europepmc]
• Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. [europepmc]
• Innovating the treatment of COPD exacerbations: a phone interactive telesystem to increase COPD Action Plan adherence. [europepmc]
• A Geographic Analysis of Racial Disparities in Use of Pulmonary Rehabilitation After Hospitalization for COPD Exacerbation. [europepmc]
• Improving the Efficiency of Respiratory Drug Delivery: A Review of Current Treatment Trends and Future Strategies for Asthma and Chronic Obstructive Pulmonary Disease. [europepmc]
• Healthcare utilization after a first hospitalization for COPD: a new approach of State Sequence Analysis based on the '6W' multidimensional model of care trajectories. [europepmc]
• Association Between Initiation of Pulmonary Rehabilitation After Hospitalization for COPD and 1-Year Survival Among Medicare Beneficiaries. [europepmc]
• Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemic. [europepmc]
• The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress. [europepmc]
• The Combination of Hemogram Indexes to Predict Exacerbation in Stable Chronic Obstructive Pulmonary Disease. [europepmc]
• Expression of long non-coding RNA LUCAT1 in patients with chronic obstructive pulmonary disease and its potential functions in regulating cigarette smoke extract-induced 16HBE cell proliferation and apoptosis. [europepmc]
• Validation of COPDPredict™: Unique Combination of Remote Monitoring and Exacerbation Prediction to Support Preventative Management of COPD Exacerbations. [europepmc]
• Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission. [europepmc]
• Anti-Inflammatory and Anti-Oxidant Properties of N-Acetylcysteine: A Fresh Perspective. [europepmc]